简短干预对比常规治疗用于PTSD的非劣效性随机对照试验方案
本研究方案计划开展首个非劣效性随机对照试验,比较单次暴露导向干预BWRT与常规治疗(TAU)对PTSD的疗效。
要点
- BWRT为单次暴露导向干预,临床经验提示可能快速且持久改善PTSD症状与功能。
- 试验采用非劣效性设计,对照为挪威门诊常规循证创伤治疗。
- 主要结局为PTSD症状变化,次要结局包括生活质量、反刍及功能认知能力。
核心结论
- 若BWRT不劣于常规治疗,该简短干预可能通过提高创伤治疗可及性并克服就医障碍,为PTSD心理治疗提供重要补充。
研究设计与样本
- 常规治疗操作化为挪威门诊提供的任何循证创伤治疗方法。
- 数据收集时间为基线(T1)、治疗后三周内(T2)及6个月随访(T3)。
关键数值与推荐
- 主要目标为比较PTSD症状变化,次要目标为比较感知生活质量、反刍、功能与认知能力变化。
- 试验注册号191548,注册日期2021年5月24日。
临床怎么用
- 若证实非劣效,单次BWRT可作为常规创伤治疗的可及性替代方案,减少等待时间与脱落。
局限性
- BWRT尚未经实证研究检验,其临床效果仅基于临床经验提示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although existing treatment methods are effective in alleviating PTSD symptoms, several barriers to care exist, such as waiting times, avoidant tendencies, shame and stigma, potentially leading to fewer people seeking therapy or premature dropouts. A potential solution to battling these barriers is Brain Working Recursive Therapy (BWRT), a single-session exposure-oriented intervention for PTSD. Although not yet subjected to empirical investigation, clinical experiences suggest an often immediate and long-lasting effect following the intervention related to patient's symptomatology and functional abilities. METHODS: The current study protocol outlines a plan to conduct the first non-inferiority randomized controlled trial aimed to explore the efficacy of BWRT compared to treatment as usual (TAU), operationalized as any evidence-based trauma treatment method administered in Norwegian out-patient clinics. Eighty-two participants will be allocated at a 1:1 ratio to one of the following treatment conditions: (1) BWRT or (2) treatment as usual. Participants will be compared on several variables, including changes in PTSD symptoms (primary objective), and changes in perceived quality of life, rumination, functional and cognitive ability (secondary objective). Data collection will take place baseline (T1), within three weeks post treatment (T2) and at 6-month follow-up (T3). DISCUSSION: Should BWRT prove to be non-inferior to treatment as usual, this brief intervention may be an important contribution to future psychological treatment for PTSD, by making trauma treatment more accessible and battling current barriers to care. TRIAL REGISTRATION: 191548, 24.05.2021. ClinicalTrials.gov PRS: Release Confirmation.
引用
- Stavland H, Refvik C, Eid J, et al. A brief intervention for PTSD versus treatment as usual: Study protocol for a non-inferiority randomized controlled trial. Trials. 2021. PMID: 34696777. doi:10.1186/s13063-021-05674-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。